| The relationship of respiratory and cardiovascular hospital admissions to the southern California wildfires of 2003 RJ Delfino, S Brummel, J Wu, H Stern, B Ostro, M Lipsett, A Winer, ... Occupational and environmental medicine 66 (3), 189-197, 2009 | 506 | 2009 |
| Neural-tube defects and antiretroviral treatment regimens in Botswana R Zash, L Holmes, M Diseko, DL Jacobson, S Brummel, G Mayondi, ... New England Journal of Medicine 381 (9), 827-840, 2019 | 394 | 2019 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing RS Gammal, MH Court, CE Haidar, OF Iwuchukwu, AH Gaur, M Alvarellos, ... Clinical Pharmacology & Therapeutics 99 (4), 363-369, 2016 | 189 | 2016 |
| Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir … S Lockman, SS Brummel, L Ziemba, L Stranix-Chibanda, K McCarthy, ... The Lancet 397 (10281), 1276-1292, 2021 | 123 | 2021 |
| Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers SL Neuhausen, S Brummel, YC Ding, CF Singer, G Pfeiler, HT Lynch, ... Breast Cancer Research 11, 1-12, 2009 | 58 | 2009 |
| Human immunodeficiency virus type 1 DNA decay dynamics with early, long-term virologic control of perinatal infection P Uprety, K Patel, B Karalius, C Ziemniak, YH Chen, SS Brummel, ... Clinical infectious diseases 64 (11), 1471-1478, 2017 | 47 | 2017 |
| Genetic Variants in the Host Restriction Factor APOBEC3G are Associated With HIV-1–Related Disease Progression and Central Nervous System Impairment in Children KK Singh, Y Wang, KP Gray, M Farhad, S Brummel, T Fenton, R Trout, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (2), 197-203, 2013 | 41 | 2013 |
| Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus–infected and perinatally exposed but uninfected youth J Alperen, S Brummel, K Tassiopoulos, CA Mellins, D Kacanek, R Smith, ... Journal of Adolescent Health 54 (3), 341-349, 2014 | 40 | 2014 |
| Executive functioning in children and adolescents with perinatal HIV infection SL Nichols, SS Brummel, RA Smith, PA Garvie, SJ Hunter, KM Malee, ... The Pediatric infectious disease journal 34 (9), 969-975, 2015 | 39 | 2015 |
| A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers YC Ding, L McGuffog, S Healey, E Friedman, Y Laitman, ... Cancer epidemiology, biomarkers & prevention 21 (8), 1362-1370, 2012 | 32 | 2012 |
| Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy G Theron, S Brummel, L Fairlie, M Pinilla, K McCarthy, M Owor, L Chinula, ... Clinical Infectious Diseases 73 (2), e312-e320, 2021 | 28 | 2021 |
| Adverse pregnancy outcomes among women who conceive on antiretroviral therapy RM Hoffman, SS Brummel, P Britto, JH Pilotto, G Masheto, L Aurpibul, ... Clinical Infectious Diseases 68 (2), 273-279, 2019 | 26 | 2019 |
| Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3 JS Currier, P Britto, RM Hoffman, S Brummel, G Masheto, E Joao, ... PLoS One 12 (5), e0176009, 2017 | 24 | 2017 |
| Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers SL Neuhausen, S Brummel, YC Ding, L Steele, KL Nathanson, ... Cancer epidemiology, biomarkers & prevention 20 (8), 1690-1702, 2011 | 24 | 2011 |
| The multi-country PROMOTE HIV antiretroviral treatment observational cohort in Sub-Saharan Africa: Objectives, design, and baseline findings TE Taha, N Yende-Zuma, J Aizire, T Chipato, L Wambuzi Ogwang, ... PloS one 13 (12), e0208805, 2018 | 20 | 2018 |
| Comparison of dried blood spot and plasma sampling for untargeted metabolomics NH Tobin, A Murphy, F Li, SS Brummel, TE Taha, F Saidi, M Owor, ... Metabolomics 17 (7), 62, 2021 | 18 | 2021 |
| Dolutegravir in pregnancy as compared with current HIV regimens in the United States K Patel, Y Huo, J Jao, KM Powis, PL Williams, D Kacanek, LM Yee, ... New England Journal of Medicine 387 (9), 799-809, 2022 | 17 | 2022 |
| Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial L Chinula, L Ziemba, S Brummel, K McCarthy, A Coletti, C Krotje, ... The Lancet HIV 10 (6), e363-e374, 2023 | 16 | 2023 |
| Safety and efficacy of DTG vs EFV and TDF vs TAF in pregnancy: IMPAACT 2010 trial L Chinula, SS Brummel, L Ziemba, L Stranix-Chibanda, A Coletti, C Krotje Conference on Retroviruses and Opportunistic Infections 11, 2020 | 16 | 2020 |
| Roles of medication responsibility, executive and adaptive functioning in adherence for children and adolescents with perinatally acquired HIV PA Garvie, SS Brummel, SM Allison, KM Malee, CA Mellins, ML Wilkins, ... The Pediatric infectious disease journal 36 (8), 751-757, 2017 | 16 | 2017 |
Daniel GillenChancellor’s Professor and Chair of Statistics, University of California, Irvine在 uci.edu 的电子邮件经过验证
